Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.04 | - |
NAV | ₹19.37 | - |
Fund Started | 06 Oct 2020 | - |
Fund Size | ₹153.72 Cr | - |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 31.04% | - |
3 Year | 15.92% | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 99.98% | - |
Cash | -0.12% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.13% |
Cipla Ltd. | 6.19% |
Max Healthcare Institute Ltd. | 5.85% |
Divi's Laboratories Ltd. | 5.67% |
Dr. Reddy's Laboratories Ltd. | 5.39% |
Apollo Hospitals Enterprise Ltd. | 5.28% |
Eli Lilly And Co | 4.99% |
Lupin Ltd. | 3.59% |
Johnson & Johnson Ltd. | 2.87% |
Novo Nordisk A/S - ADR | 2.65% |
Name | Bhavesh Jain | - |
Start Date | 01 Oct 2021 | - |
Name
Start Date
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | - |
Launch Date | 06 Oct 2020 | - |
Description
Launch Date